H-3 RECEPTOR REGULATION OF VASCULAR GASTRIN AND SOMATOSTATIN RELEASESBY THE ISOLATED RAT STOMACH

We have studied the effects of the H-3-receptor agonist (R)alpha-methy lhistamine [(R)alpha-MeHA] and the H-3-receptor antagonist thioperamid e (Thiop) on basal- and carbachol-stimulated vascular gastrin release (GR) and somatostatin release (SR) by the isolated rat stomach. Carbac hol dose-dependently stimulated and inhibited GR and SR, respectively. Maximal stimulation of GR (500 +/- 112 percent of basal; p < .01), an d maximal inhibition of SR (-62 +/- 9 percent under basal; p < .01) we re obtained with 1 mu M carbachol. Neither (R)alpha-MeHA nor Thiop, up to 10 mu M, affected GR. However, SR was dose-dependently enhanced by Thiop (25 +/- 8 percent for 10 mu M). Carbachol stimulation of GR was strongly inhibited by Thiop (30 +/- 7 percent for 100 nM and 73 +/- 1 4 percent for 1 CIM), whereas it was potentiated by (R)alpha-MeHA. Car bachol inhibition of SR was reversed by Thiop and (R)alpha-MeHA. Howev er, the reversal effect of (R)alpha-MeHA was prevented by the CCKB/gas trin receptor antagonist PD134308. These results support H-3-receptor regulation of basal and cholinergically-stimulated GR and SR.